AKT1 and prostate carcinoma: While rotenone regulates the PI3K/AKT pathway to restrict colon cancer cell proliferation, motility, and EMT progress36, palmitic acid inactivates the pathway in prostate cancer to repress cell proliferation and metastasis37.